Search
D-3082-L
go.drugbank.com/drugs/DB17440ExperimentalD-3082-L is one of the components of the human papilloma virus (HPV) type 16 E6/E7 synthetic long peptide (SLP) vaccine ISA101b.
Synonyms: ISA101 component D-3082-L, ISA101B component D-3082-LBB-1701
go.drugbank.com/drugs/DB17443InvestigationalBB-1701 is a humanized IgG1 kappa monoclonal antibody (anti-HER2 antibody) conjugated to eribulin developed by Bliss Biopharmaceutical.
F6-734
go.drugbank.com/drugs/DB17444ExperimentalF6-734 is a bispecific monoclonal antibody with affinity for anticarcinoembryonic antigen (CEA) and anti-diethylenetriamine pentaacetic acid (DTPA) (hMN-14 × m734).[A255217,A255222]
Inetetamab
go.drugbank.com/drugs/DB17457InvestigationalInetetamab is a trastuzumab analog. It differs from trastuzumab by a two amino acid variation in its Fc domain (allotype variation), and possesses an exact F(ab’)2 of trastuzumab.
TASO-001
go.drugbank.com/drugs/DB17463InvestigationalTASO-001 is a transforming growth factor (TGF)-beta 2 specific antisense oligodeoxynucleotide.
KF-0210
go.drugbank.com/drugs/DB17476InvestigationalKF-0210 is a small molecule developed by Keythera Pharmaceuticals. It is being investigated for cancers.
BI-836880
go.drugbank.com/drugs/DB17484InvestigationalBI-836880 is a humanized bispecific nanobody that targets VEGF and Ang2.
CPGJ602
go.drugbank.com/drugs/DB17485InvestigationalCPGJ602 is a recombinant anti-EGFR human-mouse chimeric monoclonal antibody.
NY-ESO-1 peptide vaccine
go.drugbank.com/drugs/DB17498InvestigationalIt contains a peptide derived from the cancer-testis antigen (NY-ESO-1).
DSP107
go.drugbank.com/drugs/DB17501InvestigationalDSP107 is a bi-functional, trimeric, fusion protein composed of sequences from the extracellular domain of SIRPα and 4-1BBL.